search Created with Sketch.
search Created with Sketch.

Advertisement

dermwire-tv-logo Created with Sketch.
dermwire-tv-logo Created with Sketch.

FDA Approvals, Acne Insights, EPI Gets Cloderm

October 9, 2018

In a flurry of approvals, FDA gives the nod to Almirall's Seysara (sarecycline), Ortho Dermatologics' Bryhali (halobetasol propionate, 0.01%) Lotion, Paratek Pharmaceuticals' Nuzyra (omadacycline), and Regeneron's Libtayo (cemiplimab). Research shows top earners across various fields in the US may share a history of acne, but other data highlight the negative impact of acne on quality of life. EPI Health has acquired the rights to Cloderm Cream, 0.1% and its authorized generic from Promius Pharma, LLC.

Advertisement

In This Series

View More

Advertisement